Anheuser-Busch has launched the first seasonal offering under its Shock Top craft beer label. Shock Top Pumpkin Wheat, a traditional Belgian-style wheat ale brewed with pumpkins and autumnal spices, will be available until January 2012 in six-packs and 12-oz. bottles.
Under fire. That is the best way to describe the current state of the proposed $29 billion mega-merger of two of the nation’s three largest pharmacy benefit managers, and the fierce resistance it is drawing from pharmacy and consumer groups.
Drug maker Warner Chilcott's diversified portfolio of drugs will help it weather generic challenges to its patents, according to a new report by Zacks Investment Research.
Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health.
L’Oréal chairman and CEO Jean-Paul Agon has been honored by AJC, a global Jewish advocacy organization, with its International Human Relations Award in recognition of Agon's "global leadership, vision and corporate citizenship."
Catalina Marketing announced on Monday that its board of directors has tapped Jamie Egasti, former CEO of the Folgers Coffee Co. and president of Procter & Gamble’s global snacks and coffee, to serve as CEO and member of the board.
The Food and Drug Administration has approved a new product for chronic obstructive pulmonary disease made by Boehringer Ingelheim Pharmaceuticals, the drug maker said.
The Federal Trade Commission has given Teva Pharmaceutical Industries the green light to acquire Frazer, Pa.-based drug maker Cephalon, but with some restrictions, Teva said.
Mylan co-founder and former chairman and CEO Milan "Mike" Puskar died Saturday, the generic drug maker said. Puskar, who retired from Mylan as chairman in 2009, was 77.
Anglo-Swedish drug maker AstraZeneca has settled patent infringement lawsuits that it filed against two companies that had sought to market generic versions of one of its drugs.
Unilever’s Gina Boswell, who was recently appointed EVP personal care for North America, has been selected as a 2011 Achiever of the Year, one of the highest awards bestowed in the beauty industry, by nonprofit Cosmetic Executive Women.
The Food and Drug Administration has approved a drug that it called the first single-pill combination treatment for Type 2 diabetes and high cholesterol.
Organix-South earlier this week launched TheraVeda Immune Support, an herbal blend of turmeric, neem and ginger, plus ashwagandha, guduchi and holy basil to support overall strength and stamina.
Venture Products earlier this week announced a new line of yoga and fitness accessories under its Shock Athletic brand name. These products complement Venture’s existing lineup of yoga mats.